학술논문

Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome
Document Type
Journal
Source
ONCOTARGET; OCT 13 2015, 6 31, p30859-p30875, 17p.
Subject
Language
English
ISSN
19492553